Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Revenue

Dermapharm Holding SE had revenue of 309.10M EUR in the quarter ending March 31, 2026, with 1.26% growth. This brings the company's revenue in the last twelve months to 1.18B, down -1.42% year-over-year. In the year 2025, Dermapharm Holding SE had annual revenue of 1.18B, down -1.43%.

• Revenue (ttm): 1.18B
• Revenue Growth: -1.42%
• P/S Ratio: 2.04
• Revenue / Employee: 337.49K
• Employees: 3,503
• Market Cap: 2.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.18B	-17.07M	-1.43%
Dec 31, 2024	1.20B	44.72M	3.89%
Dec 31, 2023	1.15B	110.19M	10.59%
Dec 31, 2022	1.04B	80.46M	8.38%
Dec 31, 2021	960.09M	151.78M	18.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error